Dow Down0.03% Nasdaq Down0.66%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS

21.08 Up 0.39(1.88%) Jul 19, 4:00PM EDT|After Hours : 21.08 0.00 (0.00%) Jul 19, 7:15PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 11,202   9,265   46,793  
Cost of Revenue -   -   -  
Gross Profit 11,202   9,265   46,793  
Operating Expenses
Research Development47,398  32,439  27,650  
Selling General and Administrative10,016  9,193  10,378  
Non Recurring10,775  9,119  12,077  
Others1,090  1,913  3,143  
Total Operating Expenses69,279  52,664  53,248  
Operating Income or Loss (58,077) (43,399) (6,455)
Income from Continuing Operations
Total Other Income/Expenses Net530  396  5,259  
Earnings Before Interest And Taxes(57,547)(43,003)(1,196)
Interest Expense1,576  1,796  1,337  
Income Before Tax(59,123)(44,799)(2,533)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(59,123)(44,799)(2,533)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (59,123) (44,799) (2,533)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (59,123) (44,799) (2,533)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.